Caerulomycin A suppresses the differentiation of naïve T cells and alleviates the symptoms of experimental autoimmune encephalomyelitis
Multiple sclerosis (MS) is a highly detrimental autoimmune disease of the central nervous system. There is no cure for it but the treatment typically focuses on subsiding severity and recurrence of the disease. Experimental autoimmune encephalomyelitis (EAE) is an animal model of MS. It is character...
Saved in:
Main Authors: | Weshely Kujur (Author), Rama Krishna Gurram (Author), Sudeep K. Maurya (Author), Sajid Nadeem (Author), Sathi Babu Chodisetti (Author), Nargis Khan (Author), Javed Naim Agrewala (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2017-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Experimental Autoimmune Encephalomyelitis Models, Disease Biology and Experimental Therapy
Published: (2012) -
The Effect of Ribavirin on Reactive Astrogliosis in Experimental Autoimmune Encephalomyelitis
by: Irena Lavrnja, et al.
Published: (2012) -
Translational utility of experimental autoimmune encephalomyelitis: recent developments
by: Guerreiro-Cacais AO, et al.
Published: (2015) -
Targeting Chemokines and Chemokine Receptors in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
by: Dhaiban S, et al.
Published: (2020) -
Reg-2, a downstream signaling protein in the ciliary neurotrophic factor survival pathway, alleviates experimental autoimmune encephalomyelitis
by: Hong eJiang, et al.
Published: (2016)